3004.90.92.37 - Containing lorazepam or its salts 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3004.90.92.37, specifically classifies medicaments containing lorazepam or its salts. These are pharmaceutical products intended for therapeutic or prophylactic use, presented in measured doses or forms suitable for retail sale. Lorazepam is a benzodiazepine typically prescribed for its sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties, often used to treat anxiety disorders, insomnia, and seizures.
This classification is distinct from its sibling category, 3004.90.92.38, which covers medicaments containing olanzapine. While both lorazepam and olanzapine are psychotherapeutic agents, they belong to different chemical classes and are indicated for distinct therapeutic applications. This subcategory, 3004.90.92.37, serves to specifically isolate products based on the presence of lorazepam, allowing for precise tariff treatment.
As a leaf node, this category does not have further subcategories. Therefore, the classification hinges on the affirmative identification of lorazepam or its salts as an active ingredient in the medicament. The form in which the product is presented (e.g., tablets, capsules, injections) and its packaging for retail sale are also key considerations for confirming its placement within heading 3004 and this specific sub-classification.